BioSpace News Archive

Biotech Bay

Insera Announces First Two Stroke Patients Treated with its Cyclical Aspiration System, CLEAR

Insera Therapeutics, Inc. announced that the first two ischemic stroke patients have been treated with its flagship cyclic aspiration system, CLEARTM.

October 8, 2019
·
2 min read
Mitsubishi Electric’s KOTSUMON® System Uses AI Video Technology to Analyze Production Line Workers’ Motions

Mitsubishi Electric Corporation announced its newly developed KOTSUMON® system uses the company’s Maisart®* artificial-intelligence technologies to extract video data for the automatic identification and analysis of specific types of human motions, such as those of workers on production lines.

October 8, 2019
·
2 min read
FDA

Novartis’ Wet AMD Drug Wins FDA Approval

The approval of Beovu was based on findings from the Phase III HAWK and HARRIER clinical trials, in which Novartis’ drug demonstrated non-inferiority versus Eylea in mean change in best-corrected visual acuity at 48 weeks.

October 8, 2019
·
2 min read
·
Alex Keown
Researchers ID Unexpected Brain Cells Involved in the Development of Multiple Sclerosis

Researchers with the University of Virginia School of Medicine have shown that a type of cell called oligodendrocyte progenitor cells play a significant role in the development of MS.

October 8, 2019
·
2 min read
·
Mark Terry
Business

4D Pharma and Merck Team to Develop Microbiome-based Vaccines

Under the terms of the deal, 4D will use its proprietary MicroRx platform with Merck’s expertise in novel vaccine development and commercialization to discover and develop Live Biotherapeutics as vaccines in up to three currently undisclosed indications.

October 8, 2019
·
2 min read
·
Mark Terry
Business

Flagship Pioneering Launches Cygnal Therapeutics

Cygnal was founded in 2017 based on discoveries made in the field of exoneural biology, which is a new understanding of how nerves and neural signaling drive human health and disease.

October 8, 2019
·
3 min read
·
Alex Keown
Policy

Acorda Appeal Snubbed by Supreme Court for MS Drug Patents

Acorda Therapeutics’ attempt to preserve its patent protection for multiple sclerosis drug Ampyra hit the proverbial wall Monday when the U.S. Supreme Court refused to hear the company’s appeal of a lower court ruling.

October 8, 2019
·
2 min read
·
Alex Keown
De-Bottlenecking Molecular Biology

Enzymatic DNA synthesis may be a still some way off, however the route to overcoming the DNA synthesis bottleneck is clearer than ever.

October 8, 2019
·
5 min read
·
David Kirk
Business

Prevail and Lonza Deepen Partnership with New Collaboration

The two companies will partner on the process development, analytical development and large-scale manufacturing for late-stage clinical and commercial supply.

October 8, 2019
·
2 min read
·
Alex Keown
Develop a 30-Day Plan to Make a Positive Impression During Your First Month on the Job

Consider including the following components in your plan.

October 8, 2019
·
3 min read
·
Katharine Hansen, PhD